GlassScriptPhysician profile
Austin L Strohbehn
NPI 1629482468
$5,218.85
in general payments reported to CMS, 2019-2025
15 companies · $2,984 in 2025
The $2,984 reported for 2025 was more than what 85% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2022: $382 · 2023: $424 · 2024: $994 · 2025: $2,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,250 · Food and Beverage: $2,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,250.00 |
| Food and Beverage | $2,152.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dutch Ophthalmic, USA | $2,562.81 | 2024-2025 | Tissueblue, Eva, Combined Machine |
| Regeneron Healthcare Solutions, INC. | $906.10 | 2022-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $584.35 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $223.64 | 2024-2025 | Syfovre |
| US Oncology Corporate, INC. | $222.10 | 2025 | |
| Astellas Pharma US INC | $191.03 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $170.83 | 2022-2024 | Xipere |
| Abbvie INC. | $124.98 | 2025 | |
| Genentech, INC. | $105.55 | 2025 | Vabysmo |
| Harrow Eye, LLC | $61.88 | 2024-2025 | Iheezo |
| Ani Pharmaceuticals, INC. | $24.96 | 2025 | Yutiq |
| Rxsight INC | $20.03 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Biogen, INC. | $16.92 | 2023 | |
| Genentech USA, INC. | $3.67 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Strohbehn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.